CEA, CAP-1 is a peptide derived from the carcinoembryonic antigen used to study epitope presentation and structural motifs in glycoprotein recognition. Its sequence supports β-turn and loop-conformation analyses. Researchers evaluate its residue-accessibility profile to map interaction hot spots. The peptide contributes to biochemical modeling of CEA-derived binding surfaces.
CAT No: C08074
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More